Zhu, J., Edenfield, W. J., Tong, H., Sun, L., Liu, A., Hu, X., Mo, F., Yu, L. A., Ji, W., Luk, A. (2026). Tri-specific immune checkpoint engineering: Clinical translation of HCB301 targeting SIRPα, PD-L1, and TGF.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.19_suppl.tps90